UBI Pharma Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 225.932 million compared to TWD 229.199 million a year ago. Operating loss was TWD 89.004 million compared to TWD 106.320 million a year ago. Net loss was TWD 89.323 million compared to TWD 107.918 million a year ago. Basic loss per share was TWD 0.63 compared to TWD 0.76 a year ago.